25860-44-0 Usage
Uses
Used in Pharmaceutical Applications:
2-Phenyl-pyrrolidine-2-carboxylic acid is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of new drugs with potential therapeutic applications.
Used in Material Science Applications:
In the field of material science, 2-Phenyl-pyrrolidine-2-carboxylic acid is used as a component in the development of new materials with specific properties. Its functional groups can contribute to the formation of novel materials with potential uses in various industries.
Used in Chemical Research:
2-Phenyl-pyrrolidine-2-carboxylic acid serves as a subject of study in chemical research, where its reactivity, stability, and possible toxicological properties are investigated. This research is crucial for understanding how the compound can be safely and effectively utilized in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 25860-44-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,8,6 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 25860-44:
(7*2)+(6*5)+(5*8)+(4*6)+(3*0)+(2*4)+(1*4)=120
120 % 10 = 0
So 25860-44-0 is a valid CAS Registry Number.
25860-44-0Relevant academic research and scientific papers
A new sparteine surrogate for asymmetric deprotonation of N-Boc pyrrolidine
Stead, Darren,O'Brien, Peter,Sanderson, Adam
supporting information; experimental part, p. 1409 - 1412 (2009/04/12)
(Chemical Equation Presented) The s-BuLi complex of a cyclohexane-derived diamine is as efficient as s-BuLi/(-)-sparteine for the asymmetric deprotonation of N-Boc pyrrolidine. This is the first example of high enantioselectivity using a non-sparteine-like diamine in such reactions. The ( S, S)-diamine is a useful (+)-sparteine surrogate and was utilized in short syntheses of (-)-indolizidine 167B and an intermediate for the synthesis of the CCK antagonist (+)-RP 66803.
